Chen L, Long X, Yang J. Diosmetin Inhibits Bladder Cancer through Suppression of the PI3K-AKT Signaling Pathway and Activation of the p53 Signal Pathway Revealed by Network Pharmacology and In Vitro Experimental Verification. Comb Chem High Throughput Screen 2026.
PMID: 42736666